GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,084,000 | +134.6% | 5,000 | +25.0% | 0.00% | – |
| Q4 2020 | $462,000 | +18.5% | 4,000 | 0.0% | 0.00% | – |
| Q3 2020 | $390,000 | -20.4% | 4,000 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $490,000 | +12.6% | 4,000 | +6.2% | 0.00% | – |
| Q3 2019 | $435,000 | -69.1% | 3,765 | -53.9% | 0.00% | -100.0% |
| Q2 2019 | $1,408,000 | -4.9% | 8,165 | -7.0% | 0.00% | 0.0% |
| Q1 2019 | $1,480,000 | +89.0% | 8,780 | +8.5% | 0.00% | 0.0% |
| Q4 2018 | $783,000 | -55.1% | 8,090 | -19.8% | 0.00% | -50.0% |
| Q3 2018 | $1,743,000 | +23.8% | 10,090 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $1,408,000 | +23.8% | 10,090 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,137,000 | -14.6% | 10,090 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,332,000 | +30.1% | 10,090 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,024,000 | +1.7% | 10,090 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,007,000 | -18.5% | 10,090 | -1.1% | 0.00% | 0.0% |
| Q1 2017 | $1,235,000 | -12.9% | 10,200 | -19.6% | 0.00% | 0.0% |
| Q4 2016 | $1,418,000 | – | 12,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |